VENTANA ANTI-MSH2 (G219-1129)MOUSE MONOCLONAL PRIMARYANTIBODY
VENTANA ANTI-MSH2 (G219-1129) MOUSEMONOCLONAL PRIMARY ANTIBODY(ANTICUERPO VENTANA ANTI-MSH2 (G219-1129)) ESTÁ DESTINADO A LA DETECCIÓNCUALITATIVA DE PROTEÍNA MSH2 ENSECCIONESDETEJIDOFIJADOCONFORMOLYEMBEBIDOENPARAFINA.ELANTICUERPOVENTANA ANTI-MSH2 (G219-1129) ESTÁ LISTOPARA USAR EN LOS INSTRUMENTOSBENCHMARKULTRA,XTYGXCONOPTIVIEWDAB IHC DETECTION KIT Y REACTIVOSAUXILIARES. ESTEPRODUCTOFORMAPARTEDEL VENTANA MMR IHC PANEL.
ANTI-MSH2 WINDOW (G219-1129) MICEMONOCLONAL PRIMARY ANTIBODY(ANTI-MSH2 WINDOW ANTIBODY (G219-1129)) IT IS INTENDED FOR THE QUALITATIVE DETECTION OF MSH2 PROTEIN IN TISSUE-FIXED SECTIONSCONFORMOLYEMBEBIDOENPARAFFIN. ELANTIBODYVENTANA ANTI-MSH2 (G219-1129) IS READY FOR USE IN BENCHMARKULTRA, XTYGXCONOPTIVIEWDAB IHC DETECTION KIT INSTRUMENTS AND AUXILIARY REAGENTS. THIS PRODUCT IS PART OF THE MMR IHC PANEL.
- Risk Class / Clase de Riesgo
- Clase II
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- ANTICUERPO MONOCLONAL
- Trade Name (English)
- MONOCLONAL ANTIBODY
- Analysis ID
- 640R2021 SSA
- Registration Date
- April 13, 2021
- Name (Spanish)
- PRODUCTOS ROCHE,S.A. DE C.V.
- Name (English)
- PRODUCTOS ROCHE,S.A. DE C.V.
Access comprehensive regulatory information for VENTANA ANTI-MSH2 (G219-1129)MOUSE MONOCLONAL PRIMARYANTIBODY (VENTANA ANTI-MSH2 (G219-1129)MOUSE MONOCLONAL PRIMARYANTIBODY) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 640R2021 SSA and manufactured by PRODUCTOS ROCHE,S.A. DE C.V.. The device was registered on April 13, 2021.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.